Volicure Trio 3mg/500mg/0.3mg Tablet SR
Marketer
HBC Lifesciences Pvt Ltd
Salt Composition
Glimepiride (3mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Volicure Trio 3mg/500mg/0.3mg Tablet SR
Tricure Combined 3mg/500mg/0.3mg Extended-Release Tablets are classified as antidiabetic agents. This triple-combination medication manages type 2 diabetes in adults by regulating blood glucose. Administer Tricure Combined with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing a balanced diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential preventative measures. Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Routine blood glucose monitoring is necessary; your doctor may also recommend blood tests to track blood cell counts and liver function.
Primary Ingredients of Volicure Trio 3mg/500mg/0.3mg Tablet SR
No text provided. Please provide the text you would like me to rephrase.
Uses of Volicure Trio 3mg/500mg/0.3mg Tablet SR
Managing Type 2 diabetes
Major Benefits of Volicure Trio 3mg/500mg/0.3mg Tablet SR:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Volicure Trio 3mg/500mg/0.3mg Tablet SR whole; avoid chewing, crushing, or fracturing. Administer on an empty stomach.
Common Side effects of Volicure Trio 3mg/500mg/0.3mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Volicure Trio 3mg/500mg/0.3mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Volicure Trio 3mg/500mg/0.3mg Extended-Release Tablets should be administered on an empty stomach.
How Volicure Trio 3mg/500mg/0.3mg Tablet SR works:
The extended-release tablet, Volicure Trio (3mg/500mg/0.3mg), is a triple-action antidiabetic medication.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Volicure Trio 3mg/500mg/0.3mg SR tablets is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The use of Volicure Trio 3mg/500mg/0.3mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Seek medical advice before taking this drug.
Breast feedingCONSULT YOUR DOCTOR
Using Volicure Trio 3mg/500mg/0.3mg SR tablets while breastfeeding is likely unsafe. Available evidence from humans indicates potential transfer to breast milk with a risk of infant harm.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.
KidneyUNSAFE
The extended-release Volicure Trio 3mg/500mg/0.3mg tablet is likely unsafe for individuals with kidney impairment and its use should be avoided. Medical advice is necessary. Furthermore, its use is contraindicated in patients experiencing severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Volicure Trio 3mg/500mg/0.3mg SR tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. In those with mild to moderate liver disease, initiation should be at a low dose; it's contraindicated in cases of severe hepatic dysfunction.
What if you forget to take Volicure Trio 3mg/500mg/0.3mg Tablet SR :
Should you forget a Volicure Trio 3mg/500mg/0.3mg SR Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Volicure Trio 3mg/500mg/0.3mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Diabetes Management |
3,018 People bought this recently